ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 179 filers reported holding ARGENX SE in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,263,070 | -18.7% | 16,810 | -17.3% | 0.02% | -17.2% |
| Q4 2022 | $7,703,508 | -40.0% | 20,335 | -44.1% | 0.03% | -38.3% |
| Q3 2022 | $12,833,000 | +31.8% | 36,350 | +41.4% | 0.05% | +14.6% |
| Q2 2022 | $9,739,000 | +1319.7% | 25,704 | +1081.2% | 0.04% | +1266.7% |
| Q1 2022 | $686,000 | -70.9% | 2,176 | -67.7% | 0.00% | -66.7% |
| Q4 2021 | $2,360,000 | +76.4% | 6,739 | +52.1% | 0.01% | +80.0% |
| Q3 2021 | $1,338,000 | +199.3% | 4,430 | +198.1% | 0.01% | +150.0% |
| Q2 2021 | $447,000 | – | 1,486 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |